136 related articles for article (PubMed ID: 6299967)
1. The in vitro activity of ceftazidime against resistant clinical isolates.
Van Landuyt HW; Denolf BL; Pyckavet M; Lambert AM
Infection; 1983; 11 Suppl 1():S23-7. PubMed ID: 6299967
[TBL] [Abstract][Full Text] [Related]
2. Comparative in vitro activity of first, second and third generation cephalosporins.
Forsgren A
Acta Pathol Microbiol Scand B; 1981 Aug; 89(4):221-5. PubMed ID: 6274143
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of N-formimidoyl thienamycin in comparison with cefotaxime, moxalactam, and ceftazidime.
Verbist L; Verhaegen J
Antimicrob Agents Chemother; 1981 Mar; 19(3):402-6. PubMed ID: 6264844
[TBL] [Abstract][Full Text] [Related]
4. [Comparative study of ceftriaxone, cefotaxime and moxalactam against 150 Gram negative strains (author's transl)].
Nasnas R; Gutmann L; Kitzis MD; Goldstein F; Acar JF
Pathol Biol (Paris); 1982 Jun; 30(6):341-4. PubMed ID: 6287385
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of ceftazidime and ceftriaxone.
Keenholtz SL; Jacobus NV; Tally FP; Gorbach SL
Clin Ther; 1983; 5(6):603-16. PubMed ID: 6313195
[TBL] [Abstract][Full Text] [Related]
6. Comparative in vitro studies of Ro 13-9904, a new cephalosporin derivative.
Eickhoff TC; Ehret J
Antimicrob Agents Chemother; 1981 Mar; 19(3):435-42. PubMed ID: 6264845
[TBL] [Abstract][Full Text] [Related]
7. [In vitro antibacterial activity of a new cephalosporin: cefpirome (HR 810). Comparison with ceftriaxone, cefotaxime, latamoxef and ceftazidime].
Le Noc P; Bryskier A; Le Noc D
Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):567-71. PubMed ID: 3534744
[TBL] [Abstract][Full Text] [Related]
8. Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests.
Jones RN; Barry AL; Thornsberry C; Gerlach EH; Fuchs PC; Gavan TL; Sommers HM
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():187-211. PubMed ID: 19802985
[TBL] [Abstract][Full Text] [Related]
9. The in vitro activity of moxalactam against 430 clinical, bacterial isolates.
Digranes A; Benonisen E; Dibb WL; Ostervold B
Acta Pathol Microbiol Immunol Scand B; 1982 Feb; 90(1):69-72. PubMed ID: 6211028
[TBL] [Abstract][Full Text] [Related]
10. Ceftazidime: in-vitro antibacterial activity and susceptibility to beta-lactamases compared with that of cefotaxime, moxalactam and other beta-lactam antibiotics.
Phillips I; Warren C; Shannon K; King A; Hanslo D
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():23-31. PubMed ID: 19802967
[TBL] [Abstract][Full Text] [Related]
11. Ceftazidime: comparative in-vitro study.
Verbist L; Verhaegen J
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():67-71. PubMed ID: 19802971
[TBL] [Abstract][Full Text] [Related]
12. [Moxalactam and cefotaxime--two new beta-lactam antibiotics compared with three well-known cephalosporins].
Baumgärtner M; Dickgiesser N; Müller S; Wundt W
Arzneimittelforschung; 1981; 31(10):1677-81. PubMed ID: 6274361
[TBL] [Abstract][Full Text] [Related]
13. Cefotetan: antimicrobial activity in-vitro compared with that of cefotaxime.
Dette GA; Knothe H; Henckel S
J Antimicrob Chemother; 1983 Jan; 11 Suppl():11-7. PubMed ID: 6302064
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of N-formimidoyl-thienamycin in comparison to that of moxalactam and cefotaxime against gentamicin-resistant gram-negative bacteria.
Pusztai-Markos Z; Pranada F
Eur J Clin Microbiol; 1982 Feb; 1(1):49-51. PubMed ID: 6293811
[TBL] [Abstract][Full Text] [Related]
15. Comparison of in-vitro activity of latamoxef (moxalactam) and ceftazidime against Pseudomonas and Enterobacteriaceae resistant to first generation cephalosporins.
Chattopadhyay B; Hall I; Curnow SR
J Antimicrob Chemother; 1983 Feb; 11(2):200-1. PubMed ID: 6219982
[No Abstract] [Full Text] [Related]
16. Antibacterial activity of moxalactam (LY-127935) compared with cefotaxime and other beta-lactam antibiotics against clinical isolates of enterobacteriacea and non-fermenters.
Verbist L
Arzneimittelforschung; 1981; 31(6):982-6. PubMed ID: 6266430
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of temocillin against clinical isolates.
Van Landuyt HW; Boelaert J; Piot P; Verbist L
Drugs; 1985; 29 Suppl 5():1-8. PubMed ID: 4029009
[TBL] [Abstract][Full Text] [Related]
18. Moxalactam (LY127935), a new semisynthetic 1-oxa-beta-lactam antibiotic with remarkable antimicrobial activity: in vitro comparison with cefamandole and tobramycin.
Jones RN; Fuchs PC; Sommers HM; Gavan TL; Barry AL; Gerlach EH
Antimicrob Agents Chemother; 1980 Apr; 17(4):750-6. PubMed ID: 6446880
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of ceftazidime, cefotaxime and piperacillin against multi-resistant gram-negative bacteria tested with a modified agar dilution method.
Hoogkamp-Korstanje JA; Meijer CA
Eur J Clin Microbiol; 1982 Jun; 1(3):166-70. PubMed ID: 6293813
[TBL] [Abstract][Full Text] [Related]
20. In vitro activities of moxalactam and cefotaxime against aerobic gram-negative bacilli.
Jorgensen JH; Crawford SA; Alexander GA
Antimicrob Agents Chemother; 1980 Jun; 17(6):937-42. PubMed ID: 6250470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
